Vermillion Inc (VRML):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Vermillion Inc (VRML) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6400
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vermillion Inc (Vermillion) is a medical device company that discovers, develops and markets diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The company’s in vitro diagnostic test OVA1, a simple blood test, which measures the levels of proteins found in the blood and then uses proprietary software to calculate a single score. Its research and development center develops and validates biomarkers and algorithms. Vermillion serves CROs, pharma, biotech and medical device industries. The company also collaborates with other academic institutions in oncology, cardiology and women’s health. Vermillion is headquartered in Austin, Texas, the US.

Vermillion Inc (VRML) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vermillion Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vermillion Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vermillion Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vermillion Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Vermillion Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Vermillion Inc, Medical Equipment, Deal Details 10
Partnerships 10
Vermillion Enters into Licensing Agreement with Quest Diagnostics 10
Equity Offering 11
Vermillion to Raise Funds through Public Offering of Securities 11
Vermillion Plans to Raise up to USD50 Million in Public Offering of Securities 12
Vermillion Plans to Raise up to USD6.8 in Public Offering of Shares 13
Vermillion Raises USD5.2 Million in Private Placement of Shares and Warrants 14
Vermillion Raises USD18.8 Million in Public Offering of Shares 15
Vermillion Raises USD10.5 Million in Private Placement of Shares and Warrants 17
Vermillion Completes Private Placement Of Shares US$18 Million Upon Exercise Of Warrants 18
Vermillion Completes Private Placement Of Shares For US$13.2 Million 19
Vermillion Inc – Key Competitors 20
Vermillion Inc – Key Employees 21
Vermillion Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Financial Announcements 24
May 14, 2018: Vermillion Reports First Quarter 2017 Financial Results 24
Mar 13, 2018: Vermillion Reports Fourth Quarter and Fiscal Year 2017 Financial Results 26
Nov 08, 2017: Vermillion Reports Third Quarter 2017 Results 27
May 11, 2017: Vermillion Reports First Quarter 2017 Results 28
Mar 29, 2017: Vermillion Reports Fourth Quarter and Full Year 2016 Results 29
Corporate Communications 31
Aug 21, 2018: Vermillion names Nancy Cocozza to its board of directors 31
Jun 13, 2018: Vermillion Appoints Chris Goulart As Senior Vice President Of Commercial Operations 32
Dec 19, 2017: Vermillion Appoints Bob Beechey to Newly Created CFO Post 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Vermillion Inc, Medical Equipment, Key Facts, 2017 2
Vermillion Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Vermillion Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vermillion Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vermillion Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vermillion Inc, Deals By Market, 2012 to YTD 2018 8
Vermillion Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Vermillion Enters into Licensing Agreement with Quest Diagnostics 10
Vermillion to Raise Funds through Public Offering of Securities 11
Vermillion Plans to Raise up to USD50 Million in Public Offering of Securities 12
Vermillion Plans to Raise up to USD6.8 in Public Offering of Shares 13
Vermillion Raises USD5.2 Million in Private Placement of Shares and Warrants 14
Vermillion Raises USD18.8 Million in Public Offering of Shares 15
Vermillion Raises USD10.5 Million in Private Placement of Shares and Warrants 17
Vermillion Completes Private Placement Of Shares US$18 Million Upon Exercise Of Warrants 18
Vermillion Completes Private Placement Of Shares For US$13.2 Million 19
Vermillion Inc, Key Competitors 20
Vermillion Inc, Key Employees 21
Vermillion Inc, Subsidiaries 22

List of Figures
Vermillion Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Vermillion Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Vermillion Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Vermillion Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Vermillion Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vermillion Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Vermillion Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vermillion Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Vermillion Inc (VRML):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KEB Hana Bank:企業の戦略・SWOT・財務情報
    KEB Hana Bank - Strategy, SWOT and Corporate Finance Report Summary KEB Hana Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • CSI Compressco LP (CCLP):石油・ガス:M&Aディール及び事業提携情報
    Summary CSI Compressco LP (CSI), formerly Compressco Partners LP, a subsidiary of TETRA Technologies Inc, is an oilfield consulting company that offers compression services and equipment for natural gas and oil production, transportation, and storage. The company's products include real-time compres …
  • Hemarina SA:製品パイプライン分析
    Summary Hemarina SA (Hemarina) is a biotechnology company, which focuses on the research and development of marine oxygen carriers for therapeutic and industrial uses. The company develops hemoglobin-based oxygen carriers (HBOCs) for organ preservation. Due to the absence of vasoconstrictor effect, …
  • Westwater Resources, Inc.:企業の戦略・SWOT・財務情報
    Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Trilogy Health Services LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Trilogy Health Services LLC (Trilogy) is a healthcare service provider that offers senior living and long-term healthcare services. The center offers services such as independent living, assisted living, skilled nursing, memory care, rehabilitation, adult day service, respite care, home heal …
  • Navidea Biopharmaceuticals Inc (NAVB)-製薬・医療分野:企業M&A・提携分析
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key product, Lymphoseek (technetium Tc 99m tilmanocept) injection, is a radiopharmaceutical agent used i …
  • Metro AG:企業のM&A・事業提携・投資動向
    Metro AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Metro AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Sotera Wireless Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Wireless Inc (Sotera Wireless) is a medical device company that provides technology products. The company develops and markets vital signs monitoring systems, ViSi Mobile systems, mobile monitor systems, and others. Its ViSi Mobile System is a platform for comprehensive vital signs mo …
  • Herbalife Nutrition Ltd (HLF):企業の財務・戦略的SWOT分析
    Herbalife Nutrition Ltd (HLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Janssen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a healthcare products provider that offers various medicines. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental …
  • Bank Otkritie Financial Corp:企業の戦略・SWOT・財務分析
    Bank Otkritie Financial Corp - Strategy, SWOT and Corporate Finance Report Summary Bank Otkritie Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • The Federal Reserve System:企業の戦略的SWOT分析
    The Federal Reserve System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Arkansas Electric Cooperative Corporation:発電所・企業SWOT分析
    Arkansas Electric Cooperative Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …
  • K.P.R. Mill Ltd:企業の戦略・SWOT・財務情報
    K.P.R. Mill Ltd - Strategy, SWOT and Corporate Finance Report Summary K.P.R. Mill Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Scilex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scilex Pharmaceuticals Inc (Scilex Pharma), a subsidiary of Sorrento Therapeutics Inc is a developer of pharmaceutical products. The company develops and commercializes branded pharmaceutical products for the treatment of pain. Its technologies include drug delivery and proprietary patch tec …
  • Sumatec Resources Bhd (SUMATEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumatec Resources Bhd (Sumatec) is an oilfield service provider that offers of construction and drilling services to the oil and gas industry. The company’s services include engineering and construction for oil and gas facilities, oil and gas assets development, supply and management of onsh …
  • Just Eat plc:企業の戦略・SWOT・財務情報
    Just Eat plc - Strategy, SWOT and Corporate Finance Report Summary Just Eat plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pakistan Petroleum Ltd (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company operates producing fields at Sui, Kandhkot, Adh …
  • Relmada Therapeutics Inc (RLMD):製薬・医療:M&Aディール及び事業提携情報
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • EnviTec Biogas AG (ETG):企業の財務・戦略的SWOT分析
    EnviTec Biogas AG (ETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆